Skip to content

Tough Talks: A Disclosure Intervention for HIV+ Young Men Who Have Sex With Men (YMSM)

Tough Talks: A Disclosure Intervention for HIV+ Young Men Who Have Sex With Men

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03414372
Enrollment
156
Registered
2018-01-29
Start date
2019-05-07
Completion date
2022-04-07
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disclosure, Hiv, HIV/AIDS

Keywords

MSM, HIV, disclosure, eHealth, virtual reality

Brief summary

Tough Talks is a virtual reality based HIV disclosure intervention that allows HIV+ individuals to practice disclosing to romantic partners. Tough Talks allows participants to have the opportunity to practice disclosing using a variety of strategies and experience different outcomes including acceptance, confusion, lack of HIV knowledge, and rejection.

Detailed description

During Phase I of this project, the investigators developed an iPad based virtual reality system that features three avatars, two virtual locations and three disclosure scenarios which represent a variety of common disclosure experiences and contexts experienced by YMSM. In Phase II the investigators will further enhance Tough Talks and develop a full-feature automated version to test via a multi-site, randomized controlled trial (RCT) through the newly created Center for Innovative Technologies (iTech) across the Prevention and Care Continuum, an NIH-funded center to support adolescent HIV research.

Interventions

BEHAVIORALTough Talks Online

Those randomized to the online condition will receive information about how to access Tough Talks online and be given their unique log-in and password information and information on how to contact study personnel for any technical issues. Arm 1 participants will have 24-hour access to all of the intervention features and will be able to access the program for additional sessions at any time. Study staff will provide reminders using text or email (participant preference) if they have not accessed the intervention at the specified time intervals.

BEHAVIORALTough Talks Clinic

Those randomized to the in-clinic condition (Arm 2) will immediately begin the Tough Talks intervention. Study staff will ensure participants are logged on and will also be available to answer technical issues should they arise. After completion, those in this arm will have an in-person follow-up visit scheduled for approximately two weeks. The in-person sessions were adapted to be delivered via Zoom or a similar HIPAA compliant platform due to the COVID-19 pandemic.

BEHAVIORALStandard of Care

Those randomized to the control arm (SOC) will receive a paper-based disclosure informational packet based on available Centers of Disease Control (CDC) guidance. At one-month, all participants will complete an online survey to assess intervention acceptability as well as to assess Social Cognitive Theory (SCT model) constructs.

Sponsors

Virtually Better, Inc.
CollaboratorINDUSTRY
National Institute of Mental Health (NIMH)
CollaboratorNIH
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Intervention model description

This study includes 3 phases: 1) formative research to refine and enhance Tough Talks with input from YMSM and their social/sexual networks; 2) (n=8) a technical pilot to optimize functionality and technical performance; and 3) (n=156) a three-arm RCT to evaluate efficacy and effectiveness of Tough Talks among HIV-infected YMSM. In the RCT, the investigators will conduct a combined efficacy/effectiveness trial to compare the intervention delivered online, in the clinic or standard of care clinic messaging. Primary outcomes will be assessed at intervention completion (1 month) and at 6 months and include HIV viral load and condomless anal intercourse (CAI).

Eligibility

Sex/Gender
MALE
Age
16 Years to 29 Years
Healthy volunteers
No

Inclusion criteria

* 16-29 years * assigned male at birth * male identified * HIV infected * Owns a mobile device or has access to a laptop or desktop computer * able to understand, read, and speak English * Reports 1 or more episodes of anal intercourse with a male partner in the last 6 months

Exclusion criteria

* HIV negative * assigned female at birth * 15 or younger * 30 or older

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Suppressed Viral LoadMonth 6Chart review or drawn for study. Viral load suppression will be defined as HIV RNA \< lower limit of detection as per the laboratory at each clinical site.

Secondary

MeasureTime frameDescription
Mean Intention to Disclose ScoreMonth 6Measured using the Intention to Disclose scale which asks a single item: I plan on telling my HIV status to all of my new partners before we have sex and is rated using a 5-point Likert-type response scale. Scores range from 1 to 5 where '1' is Strongly agree and '5' is Strongly disagree. Lower scores indicate increased intention to disclose.
Mean Disclosure Self-Efficacy ScoreMonth 6Measure of perceived ability to disclose HIV-seropositive status to casual sex partners in six scenarios. Scores were summed with higher scores indicating increased perceived ability to disclose. Six Questions were asked using a 5 point Likert Scale: 1=Absolutely sure I cannot; 2=Somewhat sure I cannot; 3=Not sure; 4=Somewhat sure I can; and 5=Absolutely sure I can. Scores range from 6-30.
Mean Consequences of Disclosure (Cost) ScoreMonth 6Measure of a participant's perceived negative consequences of disclosing of their HIV status to a partner (e.g., Relationship would get bad, Person would not want to be around me), with higher scores indicating higher perceived negative consequences of disclosure. Eight Questions rated using a 4-point Likert Scale 1=Strongly disagree 2=Disagree 3=Agree 4=Strongly Agree. Scores range from 8 to 32.
Mean Consequences of Disclosure (Rewards) ScoreMonth 6Measure of a participant's perceived positive consequences of disclosing of their HIV status to a partner (e.g., Keep them safe from HIV, Improve the relationship), with higher scores indicating higher perceived positive consequences of disclosure. Ten Questions rated using a 4-point Likert Scale 1=Strongly disagree; 2=Disagree; 3=Agree; and 4=Strongly Agree. Scores range from 10-40.
Number of Participants Who Had Condomless Anal Intercourse With a Potentially Susceptible PartnerMonth 6Number of participants at month 6 with \>/= 1 act of condomless anal intercourse with a partner who is not known to be HIV-positive within the last 3 months.
Mean Disclosure Self-Regulation (Peers) ScoreMonth 6Measured using a single question: How many of your peers are not aware of your HIV status but to whom you want to disclose? and rated using a 5-point Likert Scale: 1=None; 2=Some, but less than half; 3=About half; 4=More than half; and 5=All. Scores range from 1 to 5 with lower scores indicating increased disclosure behaviors.
Mean Disclosure Self-Regulation (Sexual Partners) ScoreMonth 6Measured using a single question: How many of your current and past sexual partners are not aware of your HIV status but to whom you want to disclose? and rated using a 5-point Likert Scale: 1=None; 2=Some, but less than half; 3=About half; 4=More than half; and 5=All. Scores range from 1 to 5 with lower scores indicating increased disclosure behaviors.
Mean Disclosure Outcome Expectations (Self-Evaluative) ScoreMonth 6Measure of how a participant anticipates their behavior impacts their feelings or assessment of HIV protective behaviors. Higher scores indicate a more favorable/stronger evaluation/endorsement of HIV protective behaviors. Participant's self-evaluation based on six questions using a 5-point Likert scale (1, strongly disagree to 5, strongly agree) ranging from 5 to 30.
Mean Disclosure Outcome Expectations (Hedonistic) ScoreMonth 6Measure of how a participant anticipates their behavior impacts their feelings or assessment of sexual pleasure or sensuality. Lower scores indicate a more favorable/stronger evaluation/endorsement of HIV protective behaviors. Participant's self-evaluation based on three questions using a 5-point Likert scale (1, strongly disagree to 5, strongly agree) ranging from 3 to 15.
Mean Disclosure Self-Regulation (Family) ScoreMonth 6Measured using a single question: How many of your immediate family members are not aware of your HIV status but to whom you want to disclose? and rated using a 5-point Likert Scale: 1=None; 2=Some, but less than half; 3=About half; 4=More than half; and 5=All. Scores range from 1 to 5 with lower scores indicating increased disclosure behaviors.

Countries

United States

Participant flow

Participants by arm

ArmCount
Tough Talks Online
Participants will use Tough Talks Online Tough Talks Online: Those randomized to the online condition will receive information about how to access Tough Talks online and be given their unique log-in and password information and information on how to contact study personnel for any technical issues. Arm 1 participants will have 24-hour access to all of the intervention features and will be able to access the program for additional sessions at any time. Study staff will provide reminders using text or email (participant preference) if they have not accessed the intervention at the specified time intervals.
53
Tough Talks Clinic
Participants will use receive Tough Talks in a clinic Tough Talks Clinic: Those randomized to the in-clinic condition (Arm 2) will immediately begin the Tough Talks intervention. Study staff will ensure participants are logged on and will also be available to answer technical issues should they arise. After completion, those in this arm will have an in-person follow-up visit scheduled for approximately two weeks. The in-person sessions were adapted to be delivered via Zoom or a similar HIPAA compliant platform due to the COVID-19 pandemic.
51
Standard of Care
Participants will receive the standard of care (SOC). Standard of Care: Those randomized to the control arm (SOC) will receive a paper-based disclosure informational packet based on available Centers of Disease Control (CDC) guidance. At one-month, all participants will complete an online survey to assess intervention acceptability as well as to assess Social Cognitive Theory (SCT model) constructs.
52
Total156

Baseline characteristics

CharacteristicTough Talks OnlineTotalStandard of CareTough Talks Clinic
Age, Continuous23.19 years
STANDARD_DEVIATION 3.5
23.78 years
STANDARD_DEVIATION 3.45
24.23 years
STANDARD_DEVIATION 3.46
23.92 years
STANDARD_DEVIATION 3.35
Ethnicity (NIH/OMB)
Hispanic or Latino
15 Participants41 Participants13 Participants13 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
38 Participants115 Participants39 Participants38 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants2 Participants1 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants3 Participants0 Participants2 Participants
Race (NIH/OMB)
Black or African American
32 Participants93 Participants28 Participants33 Participants
Race (NIH/OMB)
More than one race
4 Participants15 Participants10 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants1 Participants0 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants5 Participants0 Participants3 Participants
Race (NIH/OMB)
White
13 Participants37 Participants13 Participants11 Participants
Region of Enrollment
United States
53 Participants156 Participants52 Participants51 Participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants0 Participants
Sex: Female, Male
Male
53 Participants156 Participants52 Participants51 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 530 / 511 / 52
other
Total, other adverse events
0 / 530 / 510 / 52
serious
Total, serious adverse events
0 / 530 / 510 / 52

Outcome results

Primary

Number of Participants With Suppressed Viral Load

Chart review or drawn for study. Viral load suppression will be defined as HIV RNA \< lower limit of detection as per the laboratory at each clinical site.

Time frame: Month 6

Population: Data are reported for those participants who had a Month 6 viral load assessment.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Tough Talks OnlineNumber of Participants With Suppressed Viral Load29 Participants
Tough Talks ClinicNumber of Participants With Suppressed Viral Load31 Participants
Standard of CareNumber of Participants With Suppressed Viral Load30 Participants
Secondary

Mean Consequences of Disclosure (Cost) Score

Measure of a participant's perceived negative consequences of disclosing of their HIV status to a partner (e.g., Relationship would get bad, Person would not want to be around me), with higher scores indicating higher perceived negative consequences of disclosure. Eight Questions rated using a 4-point Likert Scale 1=Strongly disagree 2=Disagree 3=Agree 4=Strongly Agree. Scores range from 8 to 32.

Time frame: Month 6

Population: Participants could choose not to respond to any of the eight questions. Responses for participants who chose not to respond to any of the eight questions were not counted.

ArmMeasureValue (MEAN)Dispersion
Tough Talks OnlineMean Consequences of Disclosure (Cost) Score23.40 score on a scaleStandard Deviation 8.19
Tough Talks ClinicMean Consequences of Disclosure (Cost) Score24.07 score on a scaleStandard Deviation 8.84
Standard of CareMean Consequences of Disclosure (Cost) Score19.20 score on a scaleStandard Deviation 8.95
Secondary

Mean Consequences of Disclosure (Rewards) Score

Measure of a participant's perceived positive consequences of disclosing of their HIV status to a partner (e.g., Keep them safe from HIV, Improve the relationship), with higher scores indicating higher perceived positive consequences of disclosure. Ten Questions rated using a 4-point Likert Scale 1=Strongly disagree; 2=Disagree; 3=Agree; and 4=Strongly Agree. Scores range from 10-40.

Time frame: Month 6

Population: Participants could choose not to respond to any of the ten questions. Responses for participants who chose not to respond to any of the ten questions were not counted.

ArmMeasureValue (MEAN)Dispersion
Tough Talks OnlineMean Consequences of Disclosure (Rewards) Score32.22 score on a scaleStandard Deviation 6.02
Tough Talks ClinicMean Consequences of Disclosure (Rewards) Score34.18 score on a scaleStandard Deviation 6.15
Standard of CareMean Consequences of Disclosure (Rewards) Score34.31 score on a scaleStandard Deviation 5.35
Secondary

Mean Disclosure Outcome Expectations (Hedonistic) Score

Measure of how a participant anticipates their behavior impacts their feelings or assessment of sexual pleasure or sensuality. Lower scores indicate a more favorable/stronger evaluation/endorsement of HIV protective behaviors. Participant's self-evaluation based on three questions using a 5-point Likert scale (1, strongly disagree to 5, strongly agree) ranging from 3 to 15.

Time frame: Month 6

Population: Although the protocol was not amended to remove this assessment, this scale was not used as study staff anticipated the questions included may be offensive to young participants.

Secondary

Mean Disclosure Outcome Expectations (Self-Evaluative) Score

Measure of how a participant anticipates their behavior impacts their feelings or assessment of HIV protective behaviors. Higher scores indicate a more favorable/stronger evaluation/endorsement of HIV protective behaviors. Participant's self-evaluation based on six questions using a 5-point Likert scale (1, strongly disagree to 5, strongly agree) ranging from 5 to 30.

Time frame: Month 6

Population: Although the protocol was not amended to remove this assessment, this scale was not used as study staff anticipated the questions included may be offensive to young participants.

Secondary

Mean Disclosure Self-Efficacy Score

Measure of perceived ability to disclose HIV-seropositive status to casual sex partners in six scenarios. Scores were summed with higher scores indicating increased perceived ability to disclose. Six Questions were asked using a 5 point Likert Scale: 1=Absolutely sure I cannot; 2=Somewhat sure I cannot; 3=Not sure; 4=Somewhat sure I can; and 5=Absolutely sure I can. Scores range from 6-30.

Time frame: Month 6

Population: Participants could choose not to respond to any of the six questions. Responses for participants who chose not to respond to any of the six questions were not counted.

ArmMeasureValue (MEAN)Dispersion
Tough Talks OnlineMean Disclosure Self-Efficacy Score22.89 score on a scaleStandard Deviation 7.69
Tough Talks ClinicMean Disclosure Self-Efficacy Score23.03 score on a scaleStandard Deviation 6.54
Standard of CareMean Disclosure Self-Efficacy Score25.64 score on a scaleStandard Deviation 7.24
Secondary

Mean Disclosure Self-Regulation (Family) Score

Measured using a single question: How many of your immediate family members are not aware of your HIV status but to whom you want to disclose? and rated using a 5-point Likert Scale: 1=None; 2=Some, but less than half; 3=About half; 4=More than half; and 5=All. Scores range from 1 to 5 with lower scores indicating increased disclosure behaviors.

Time frame: Month 6

Population: Participants were free to choose not to answer this question. Data reported for all non-missing values.

ArmMeasureValue (MEAN)Dispersion
Tough Talks OnlineMean Disclosure Self-Regulation (Family) Score2.57 score on a scaleStandard Deviation 1.53
Tough Talks ClinicMean Disclosure Self-Regulation (Family) Score2.51 score on a scaleStandard Deviation 1.48
Standard of CareMean Disclosure Self-Regulation (Family) Score2.59 score on a scaleStandard Deviation 1.58
Secondary

Mean Disclosure Self-Regulation (Peers) Score

Measured using a single question: How many of your peers are not aware of your HIV status but to whom you want to disclose? and rated using a 5-point Likert Scale: 1=None; 2=Some, but less than half; 3=About half; 4=More than half; and 5=All. Scores range from 1 to 5 with lower scores indicating increased disclosure behaviors.

Time frame: Month 6

Population: Participants were free to choose not to answer this question. Data reported for all non-missing values.

ArmMeasureValue (MEAN)Dispersion
Tough Talks OnlineMean Disclosure Self-Regulation (Peers) Score2.49 score on a scaleStandard Deviation 1.49
Tough Talks ClinicMean Disclosure Self-Regulation (Peers) Score2.33 score on a scaleStandard Deviation 1.18
Standard of CareMean Disclosure Self-Regulation (Peers) Score2.67 score on a scaleStandard Deviation 1.49
Secondary

Mean Disclosure Self-Regulation (Sexual Partners) Score

Measured using a single question: How many of your current and past sexual partners are not aware of your HIV status but to whom you want to disclose? and rated using a 5-point Likert Scale: 1=None; 2=Some, but less than half; 3=About half; 4=More than half; and 5=All. Scores range from 1 to 5 with lower scores indicating increased disclosure behaviors.

Time frame: Month 6

Population: Participants were free to choose not to answer this question. Data reported for all non-missing values.

ArmMeasureValue (MEAN)Dispersion
Tough Talks OnlineMean Disclosure Self-Regulation (Sexual Partners) Score2.08 score on a scaleStandard Deviation 1.4
Tough Talks ClinicMean Disclosure Self-Regulation (Sexual Partners) Score1.68 score on a scaleStandard Deviation 1.03
Standard of CareMean Disclosure Self-Regulation (Sexual Partners) Score1.71 score on a scaleStandard Deviation 1.22
Secondary

Mean Intention to Disclose Score

Measured using the Intention to Disclose scale which asks a single item: I plan on telling my HIV status to all of my new partners before we have sex and is rated using a 5-point Likert-type response scale. Scores range from 1 to 5 where '1' is Strongly agree and '5' is Strongly disagree. Lower scores indicate increased intention to disclose.

Time frame: Month 6

Population: Participants were free to choose not to answer this question. Data reported for all non-missing values.

ArmMeasureValue (MEAN)Dispersion
Tough Talks OnlineMean Intention to Disclose Score1.45 score on a scaleStandard Deviation 0.5
Tough Talks ClinicMean Intention to Disclose Score1.33 score on a scaleStandard Deviation 0.47
Standard of CareMean Intention to Disclose Score1.15 score on a scaleStandard Deviation 0.36
Secondary

Number of Participants Who Had Condomless Anal Intercourse With a Potentially Susceptible Partner

Number of participants at month 6 with \>/= 1 act of condomless anal intercourse with a partner who is not known to be HIV-positive within the last 3 months.

Time frame: Month 6

Population: Data are reported for those participants who completed Month 6 survey and for which non-missing data are present.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Tough Talks OnlineNumber of Participants Who Had Condomless Anal Intercourse With a Potentially Susceptible Partner11 Participants
Tough Talks ClinicNumber of Participants Who Had Condomless Anal Intercourse With a Potentially Susceptible Partner6 Participants
Standard of CareNumber of Participants Who Had Condomless Anal Intercourse With a Potentially Susceptible Partner8 Participants

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026